HealthChain Project: CardiacSense Revolutionizing Healthcare Monitoring Across Europe
March 26, 2024
March 26, 2024
October 2022
27.07.2022
26.07.2022
30.07.2021
10.02.2021
10.02.2021
11/01/2021
Patients can now be monitored continuously and extensively at home, reducing hospitalization and saving healthcare expenditure…
4/01/2021
Eldad Shemesh, CardiacSense Funder & CEO on Keeping Time to Market during COVID
7.6.2020
14.05.2020
11.04.2020
In a time of social distancing and isolation, technology is enabling patients, caregivers, and clinicians to communicate and monitor health remotely.
CardiacSense has developed a wearable for continuously monitoring vital signs of either inpatients or outpatients.
January 6, 2023
CardiacSense was granted FDA clearance for ECG, Beat-by-Beat Heart Rate, and Oxygen Saturation (SpO2)
10.02.2021
The watch will begin shipping in EU as a medical device for continuous…
6.8.2020
This is the first medical wristwatch to receive medical regulatory approval for beat by beat heart rate monitoring and A-Fib detection with ECG accuracy
7.6.2020
The agreement was signed with a distributor for the company’s product, which monitors detects fever, respiratory and chronic diseases as well as heart arrhythmias at a uniquely precise level of an ECG device
26.05.2020
The Company will enable patients to benefit from Cloud-based medical monitoring, on a monthly fee
24.04.2020
CardiacSense is a leading manufacturer of a range of wearable devices for the continuous monitoring of heart arrhythmias and blood pressure